Spain
Point Pressure, founded in 2022, is a promising player within the Health Care and Health and Wellness industries. Based in Spain, the company is focused on developing innovative medical devices that address spasticity, a common condition experienced by patients with chronic diseases. Their flagship product offers a non-invasive physical treatment aimed at enhancing the mobility of affected limbs, positioning the company at the forefront of spasticity treatment advancements.
Emphasizing their mission to bring the "next big leap in spasticity treatments," Point Pressure has already attracted early-stage interest, securing a Seed investment as of March 1, 2023. The investment underscores the growing confidence in their technology and market potential. Despite the absence of disclosed investors, the seed funding marks a crucial step in their journey, paving the way for future growth and development. Investors may find Point Pressure appealing for its innovative approach and potential for significant impact in a key medical field.
